Bavarian Nordic A/S – Report on the Results of the Annual General Meeting, held April 20, 2021
COPENHAGEN, Denmark, April 20, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with…
Pharmaceuticals, Biotechnology and Life Sciences
COPENHAGEN, Denmark, April 20, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held the Annual General Meeting with…
AGOURA HILLS, Calif., April 20, 2021 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (“Oncotelic” or the “Company”) (OTCQB:OTLC), a leading developer…
Pittsburgh, April 20, 2021 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat degenerative…
Firm publishes summary of evidence showing lack of efficacy and risksWEST CONSHOHOCKEN, Pa., April 20, 2021 (GLOBE NEWSWIRE) — To…
04_20 PR Image Delta 8 THC Tauri-Gum™ Blister Pack Sleeve This Initial Production Run has Been Doubled, Due to Strong…
ROCKVILLE, MD, April 19, 2021 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing…
HOLLISTON, Mass., April 19, 2021 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for first…
David Hovland, Ph.D., to serve as Chief Regulatory Officer and Bryan Smith, J.D. as General Counsel, Corporate Secretary, and Chief…
Daix (France), April 19, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development…
Daix (France), April 19, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA) is pleased to announce the appointment of Martine…